Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of an Oral Phosphodiesterase Inhibitor (Apremilast) for Atopic Dermatitis in Adults

NCT01393158 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT01393158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01393158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of an Oral Phosphodiesterase Inhibitor (Apremilast) for Atopic Dermatitis in Adults
Lead sponsor
Oregon Health and Science University
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2009
Completion date
July 31, 2011
Enrollment
16 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis